---
figid: PMC3794713__nihms500992f1
figlink: /pmc/articles/PMC3794713/figure/F1/
number: F1
caption: 'Simplified overview of commonly mutated oncogenes, tumor suppressors, and
  pathways in endocrine cancer. In the mitogen-activated protein kinase (MAPK) pathway
  (right center), extracellular ligands activate receptor kinases such as RET, VEGFR,
  PDGFR, and others, initiating the RAS/RAF/MEK/ERK signaling cascade, resulting in
  gene transcription and proliferation. Activating mutations in these proteins lead
  to constitutive signaling. In the phosphatidylinositol 3-kinase (PI3K) cascade (right
  side), receptor activation causes activation of Akt, also affecting cellular survival
  and regulating apoptosis. Mammalian target of rapamycin (mTOR) signaling promotes
  survival and is stimulated by Akt and repressed by TMEM127. In neurofibromatosis
  type 1, loss of NF1 function prevents termination of RAS signaling. In von Hippel-Lindau
  syndrome, VHL (left top) targets hypoxia-inducible factor proteins for ubiquitination
  (Ub) and proteasomal degradation. When HIF persists due to mutated VHL, continuous
  activation of hypoxia genes leads to angiogenesis and tumor development. In the
  mitochondrion (left side), defects in subunits of complex II, SDHA, B, C, D, and
  assembly factor 2 (AF2), impair electron transport and induce a pseudo-hypoxic state.
  MAX (in nucleus) interacts with MYC and other transcription factors to repress cell
  growth and loss of function allows proliferation. S: succinate, F: fumarate, OH-P:
  hydroxy-proline residue, PIP2,3: Phosphatidylinositol bis- or tris-phosphate. Adapted
  from Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: understanding
  the complexities of the genetic background. Cancer Genet. 2012;205:1; with permission.'
pmcid: PMC3794713
papertitle: Translational Research in Endocrine Surgery.
reftext: Scott K. Sherman, et al. Surg Oncol Clin N Am. ;22(4):857-884.
pmc_ranked_result_index: '105380'
pathway_score: 0.9598563
filename: nihms500992f1.jpg
figtitle: Simplified overview of commonly mutated oncogenes, tumor suppressors, and
  pathways in endocrine cancer
year: ''
organisms: Homo sapiens
ndex: ecaabde1-dede-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3794713__nihms500992f1.html
  '@type': Dataset
  description: 'Simplified overview of commonly mutated oncogenes, tumor suppressors,
    and pathways in endocrine cancer. In the mitogen-activated protein kinase (MAPK)
    pathway (right center), extracellular ligands activate receptor kinases such as
    RET, VEGFR, PDGFR, and others, initiating the RAS/RAF/MEK/ERK signaling cascade,
    resulting in gene transcription and proliferation. Activating mutations in these
    proteins lead to constitutive signaling. In the phosphatidylinositol 3-kinase
    (PI3K) cascade (right side), receptor activation causes activation of Akt, also
    affecting cellular survival and regulating apoptosis. Mammalian target of rapamycin
    (mTOR) signaling promotes survival and is stimulated by Akt and repressed by TMEM127.
    In neurofibromatosis type 1, loss of NF1 function prevents termination of RAS
    signaling. In von Hippel-Lindau syndrome, VHL (left top) targets hypoxia-inducible
    factor proteins for ubiquitination (Ub) and proteasomal degradation. When HIF
    persists due to mutated VHL, continuous activation of hypoxia genes leads to angiogenesis
    and tumor development. In the mitochondrion (left side), defects in subunits of
    complex II, SDHA, B, C, D, and assembly factor 2 (AF2), impair electron transport
    and induce a pseudo-hypoxic state. MAX (in nucleus) interacts with MYC and other
    transcription factors to repress cell growth and loss of function allows proliferation.
    S: succinate, F: fumarate, OH-P: hydroxy-proline residue, PIP2,3: Phosphatidylinositol
    bis- or tris-phosphate. Adapted from Fishbein L, Nathanson KL. Pheochromocytoma
    and paraganglioma: understanding the complexities of the genetic background. Cancer
    Genet. 2012;205:1; with permission.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK10
  - VHL
  - MAPK9
  - HIF1A
  - MAPK1
  - AKT2
  - ARNT
  - NF1
  - BRAF
  - AKT1
  - TMEM127
  - MYC
  - MAPK3
  - TP53
  - PIK3R6
  - PIK3CB
  - MTOR
  - AKT3
  - WDTC1
  - MAPK11
  - PIK3R5
  - PIK3CD
  - SDHB
  - MAPK8
  - RPTOR
  - RET
  - PIK3R4
  - MAPK14
  - MAPK13
  - NRAS
  - KRAS
  - MAP2K1
  - MAP2K2
  - PIK3R3
  - PIK3CA
  - MAX
  - PIK3CG
  - HRAS
  - MAPK12
  - Cancer
  - Lung cancer
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: ERK/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HIF-1B
  symbol: HIF-1beta
  source: hgnc_alias_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TMEM127
  symbol: TMEM127
  source: hgnc_symbol
  hgnc_symbol: TMEM127
  entrez: '55654'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: ERK/MAPK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: SDH
  symbol: SDH
  source: hgnc_prev_symbol
  hgnc_symbol: SDHB
  entrez: '6390'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: RET
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAX
  symbol: MAX
  source: hgnc_symbol
  hgnc_symbol: MAX
  entrez: '4149'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC3794713__F1
redirect_from: /figures/PMC3794713__F1
figtype: Figure
---
